M2A-38 CUP NON FLARED SZ 62MM
Report
- Report Number
- 0001825034-2019-00236
- Event Type
- Injury
- Date Received
- January 21, 2019
- Date of Event
- September 26, 2018
- Report Date
- April 25, 2019
- Manufacturer
- ZIMMER BIOMET, INC.
- Product Code
- KWA
- PMA / PMN Number
- K011110
- Removal / Correction Number
- N/A
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OR, US
- Reporter Occupation
- PHYSICIAN
Narratives
THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM THE CUSTOMER. DHR WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. ROOT CAUSE WAS UNABLE TO BE DETERMINED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.
NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.
(B)(4). CONCOMITANT MEDICAL PRODUCTS: 11-173662, M2A 38MM MOD HD STD NK, 040280, 11-103206, TAPERLOC POR LAT FMRL 12.5X145, 151700. REPORT SOURCE: LEGAL. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001825034-2019-00235 , 0001825034-2019-00237. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED.
IT WAS REPORTED THAT THE PATIENT'S LEFT HIP WAS REVISED APPROX. 12 YEARS POST IMPLANTATION DUE TO METALLOSIS WITH NEAR COMPLETE DESTRUCTION OF THE POSTLATERAL CORTEX OF THE PROXIMAL FEMORAL FEMUR AND GREATER TROCHANTERIC FRACTURE. BEFORE REVISION, PATIENT HAD A FALL. IMAGING CONFIRMED THAT THE IMPACT HAD SHATTERED THE LEFT HIP BONE. ATTEMPTS HAVE BEEN MADE AND ADDITIONAL INFORMATION ON THE REPORTED EVENT IS UNAVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 56851 | M2A-38 CUP NON FLARED SZ 62MM | PROSTHESIS, HIP | KWA | ZIMMER BIOMET, INC. | N/A | 256700 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| R |